Neuphoria Therapeutics Inc.: Form 6-K, filed Mar 15, 2024
Filed with the SEC on Mar 15, 2024 and accepted by EDGAR at Mar 15, 2024, 10:06 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-24-031859. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.